DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Cipla Share Price Live Updates: Cipla News

Economic Times 4 hrs ago·12 Oct 2026, 4:17 am

Cipla, a major pharmaceutical company, has been in the news recently, with investors closely tracking its share price movements. The company is a key player in the Indian market, known for its diverse portfolio of generic medicines and specialty formulations. The recent updates likely relate to broader market trends, corporate announcements, or sector-specific developments that have influenced investor sentiment.

For investors, this news is significant because Cipla's performance often reflects the health of the broader pharmaceutical sector. Any updates regarding regulatory changes, product launches, or financial results can impact the stock's valuation. Retail investors should monitor these developments to understand how they might affect the company's growth trajectory and market position.

Moving forward, investors should keep an eye on Cipla's quarterly earnings reports, regulatory approvals, and any strategic initiatives. These factors will provide clarity on the company's operational performance and future prospects. Staying informed about such updates will help investors make well-reasoned decisions in line with their investment goals.